Davide Lombardi

1.6k total citations
57 papers, 1.0k citations indexed

About

Davide Lombardi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Davide Lombardi has authored 57 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 16 papers in Cancer Research. Recurrent topics in Davide Lombardi's work include Cancer Treatment and Pharmacology (23 papers), Chemotherapy-related skin toxicity (11 papers) and Breast Cancer Treatment Studies (11 papers). Davide Lombardi is often cited by papers focused on Cancer Treatment and Pharmacology (23 papers), Chemotherapy-related skin toxicity (11 papers) and Breast Cancer Treatment Studies (11 papers). Davide Lombardi collaborates with scholars based in Italy, Switzerland and Ukraine. Davide Lombardi's co-authors include Diana Crivellari, Andrea Veronesi, Simona Scalone, Gianmaria Miolo, Simon Spazzapan, Maria Donatella Magri, Elena Muraro, Riccardo Dolcetti, Giovanni Martinelli and Ettore Bidoli and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Davide Lombardi

56 papers receiving 976 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Davide Lombardi Italy 17 609 308 211 210 97 57 1.0k
Vincenzo Sforza Italy 18 680 1.1× 362 1.2× 194 0.9× 380 1.8× 84 0.9× 58 1.2k
Thomas Makatsoris Greece 22 1.0k 1.7× 338 1.1× 198 0.9× 362 1.7× 54 0.6× 85 1.5k
Michael Xiang United States 16 351 0.6× 295 1.0× 203 1.0× 475 2.3× 57 0.6× 68 1.1k
Ernesto Wasserman United States 17 812 1.3× 358 1.2× 377 1.8× 418 2.0× 70 0.7× 35 1.2k
Diane Savarese United States 16 576 0.9× 526 1.7× 184 0.9× 274 1.3× 56 0.6× 24 1.2k
Mustafa Al-Mubarak Canada 7 747 1.2× 302 1.0× 397 1.9× 212 1.0× 158 1.6× 13 1.1k
Adriano Gravina Italy 16 591 1.0× 317 1.0× 171 0.8× 193 0.9× 100 1.0× 53 958
Gian Luigi Cetto Italy 19 666 1.1× 183 0.6× 369 1.7× 290 1.4× 97 1.0× 59 1.1k
Elisa Zanardi Italy 16 355 0.6× 420 1.4× 170 0.8× 177 0.8× 48 0.5× 56 785
Zakaria Einbeigi Sweden 18 457 0.8× 189 0.6× 372 1.8× 360 1.7× 210 2.2× 54 1.0k

Countries citing papers authored by Davide Lombardi

Since Specialization
Citations

This map shows the geographic impact of Davide Lombardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davide Lombardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davide Lombardi more than expected).

Fields of papers citing papers by Davide Lombardi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Davide Lombardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davide Lombardi. The network helps show where Davide Lombardi may publish in the future.

Co-authorship network of co-authors of Davide Lombardi

This figure shows the co-authorship network connecting the top 25 collaborators of Davide Lombardi. A scholar is included among the top collaborators of Davide Lombardi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Davide Lombardi. Davide Lombardi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buonadonna, Angela, Simona Scalone, Davide Lombardi, et al.. (2023). Prospective, Multicenter Phase II Trial of Non-Pegylated Liposomal Doxorubicin Combined with Ifosfamide in First-Line Treatment of Advanced/Metastatic Soft Tissue Sarcomas. Cancers. 15(20). 5036–5036. 1 indexed citations
2.
Corona, Giuseppe, Angela Buonadonna, Davide Lombardi, et al.. (2023). Pharmacometabolomics of trabectedin in metastatic soft tissue sarcoma patients. Frontiers in Pharmacology. 14. 1212634–1212634. 3 indexed citations
3.
Vignoli, Alessia, Gianmaria Miolo, Leonardo Tenori, et al.. (2023). Novel metabolomics-biohumoral biomarkers model for predicting survival of metastatic soft-tissue sarcomas. iScience. 26(10). 107678–107678. 2 indexed citations
4.
Muraro, Elena, Mariangela De Zorzi, Gianmaria Miolo, et al.. (2022). KIR-HLA Functional Repertoire Influences Trastuzumab Efficiency in Patients With HER2-Positive Breast Cancer. Frontiers in Immunology. 12. 791958–791958. 4 indexed citations
5.
Cappelli, Carlo, Ilenia Pirola, Elena Gandossi, et al.. (2021). Ultrasound of benign thyroid nodules: A 120 months follow‐up study. Clinical Endocrinology. 94(5). 866–871. 6 indexed citations
6.
Bianco, Paola Del, Mario Romano, Gabriella Rossi, et al.. (2021). Long-Term Outcomes Using Electron IOERT APBI for Early Stage Breast Cancer: The Verona University Hospital Experience. Clinical Breast Cancer. 22(2). e167–e172. 2 indexed citations
7.
Basile, Debora, Paola Di Nardo, Carla Corvaja, et al.. (2019). Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside. Cancers. 11(6). 857–857. 89 indexed citations
8.
9.
Carli, Paolo, Loredana Militello, Gianmaria Miolo, et al.. (2015). Retreatment with trastuzumab after progression on lapatinib-based therapy in heavily pretreated HER2-positive metastatic breast cancer: a single-institution experience.. PubMed. 100(6). 605–11. 2 indexed citations
10.
11.
Tuzi, Alessandro, Davide Lombardi, Diana Crivellari, et al.. (2013). Epirubicin and docetaxel as neoadjuvant treatment of hormone receptor positive, HER-2 negative breast cancer: findings from two successive phase II studies. Radiology and Oncology. 47(1). 57–62. 2 indexed citations
12.
Crivellari, Diana, Simon Spazzapan, Davide Lombardi, et al.. (2012). Lapatinib-based therapy in heavily pretreated HER2-positive metastatic breast cancer: a single institution experience.. PubMed. 98(1). 33–8. 4 indexed citations
13.
Crivellari, Diana, Davide Lombardi, Loredana Militello, et al.. (2012). Lapatinib-Based Therapy in Heavily Pretreated HER2-Positive Metastatic Breast Cancer: A Single Institution Experience. Tumori Journal. 98(1). 33–38. 4 indexed citations
14.
Muraro, Elena, Debora Martorelli, Gianmaria Miolo, et al.. (2011). A different immunologic profile characterizes patients with HER-2-overexpressing and HER-2-negative locally advanced breast cancer: implications for immune-based therapies. Breast Cancer Research. 13(6). R117–R117. 32 indexed citations
15.
Miolo, Gianmaria, Ettore Bidoli, Davide Lombardi, et al.. (2011). Weekly paclitaxel in heavily pretreated ovarian cancer patients: does this treatment still provide further advantages?. Archives of Gynecology and Obstetrics. 285(2). 499–503. 1 indexed citations
16.
Miolo, Gianmaria, Paolo Baldo, Ettore Bidoli, et al.. (2009). Incidence of Palmar-Plantar Erythrodysesthesia in Pretreated and Unpretreated Patients Receiving Pegylated Liposomal Doxorubicin. Tumori Journal. 95(6). 687–690. 3 indexed citations
17.
Pagani, Olivia, Cristiana Sessa, Franco Nolè, et al.. (2005). Dose-finding study of weekly docetaxel, anthracyclines plus fluoropyrimidines as first-line treatment in advanced breast cancer. Annals of Oncology. 16(10). 1609–1617. 3 indexed citations
18.
Sorio, Roberto, et al.. (2003). Ifosfamide in Advanced/Disseminated Breast Cancer. Oncology. 65(Suppl. 2). 55–58. 6 indexed citations
19.
Crivellari, Diana, Davide Lombardi, Simon Spazzapan, Andrea Veronesi, & Giuseppe Toffoli. (2003). New oral drugs in older patients: a review of idarubicin in elderly patients. Critical Reviews in Oncology/Hematology. 49(2). 153–163. 26 indexed citations
20.
Pagani, Olivia, Cristiana Sessa, Franco Nolè, et al.. (2000). Epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer: A multicentric phase I–II study. Annals of Oncology. 11(8). 985–992. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vincenzo Sforza Breakdown of academic impact, for papers by Thomas Makatsoris Breakdown of academic impact, for papers by Michael Xiang Breakdown of academic impact, for papers by Ernesto Wasserman Breakdown of academic impact, for papers by Diane Savarese Breakdown of academic impact, for papers by Mustafa Al-Mubarak Breakdown of academic impact, for papers by Adriano Gravina Breakdown of academic impact, for papers by Gian Luigi Cetto Breakdown of academic impact, for papers by Elisa Zanardi Breakdown of academic impact, for papers by Zakaria Einbeigi
Rankless by CCL
2026